Page last updated: 2024-08-21

malondialdehyde and Cortical Lewy Body Disease

malondialdehyde has been researched along with Cortical Lewy Body Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ayala, V; Dalfó, E; Ferrer, I; Martínez, A; Pamplona, R; Portero-Otín, M	1

Other Studies

1 other study(ies) available for malondialdehyde and Cortical Lewy Body Disease

Article	Year
Evidence of oxidative stress in the neocortex in incidental Lewy body disease. Journal of neuropathology and experimental neurology, 2005, Volume: 64, Issue:9 Topics: Aged; Aged, 80 and over; Aldehydes; alpha-Synuclein; Blotting, Western; Docosahexaenoic Acids; Electrophoresis, Gel, Two-Dimensional; Fatty Acids; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lewy Body Disease; Male; Malondialdehyde; Mass Spectrometry; Neocortex; Nerve Tissue Proteins; Oxidative Stress; Parkinson Disease; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Synucleins	2005

Article

Year

Evidence of oxidative stress in the neocortex in incidental Lewy body disease.

Journal of neuropathology and experimental neurology, 2005, Volume: 64, Issue:9

Topics: Aged; Aged, 80 and over; Aldehydes; alpha-Synuclein; Blotting, Western; Docosahexaenoic Acids; Electrophoresis, Gel, Two-Dimensional; Fatty Acids; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lewy Body Disease; Male; Malondialdehyde; Mass Spectrometry; Neocortex; Nerve Tissue Proteins; Oxidative Stress; Parkinson Disease; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Synucleins

2005